癌症干细胞
干细胞
癌症研究
干细胞标记物
CD44细胞
生物
祖细胞
肝癌
癌症
病理
造血
作者
Qin Wang,Ning Chen,Chunna Yu,Zefeng Wei,Zewu Li,Zhenzhen Jin
出处
期刊:Journal of B.U.ON. : official journal of the Balkan Union of Oncology
日期:2019-07-01
卷期号:24 (4): 1408-1413
被引量:1
摘要
Purpose The purpose of the study is to identify the Cancer Stem Cells (CSCs) and to determine their expression profiles in different pathological stages of liver cancer by using multiple markers Methods: In this study, the expression profiles of CD133 and CD13, along with those of stem cell markers Oct4 and SOX2, were analyzed using immunohistochemistry and immunoblotting to clarify the character of CSCs in different stages of liver cancer. Results CD133 liver cancer cells were injected into mice, and the tissues were processed for histology. The histological data revealed the progression of liver cancer. Immunohistochemical analysis showed the strong expression of CD133 in metastatic cancer. In contrast, the expression of CD13 in both primary and metastatic liver cancer was found to be very strong. Interestingly, the expression levels of Oct4 and SOX2 were found to be upregulated in primary tumors, but, in the metastatic stage, their expression was downregulated. The immunoblot analysis also confirmed the same result. Conclusions Our findings demonstrate that tumor-suppressor proteins Oct4 and SOX2 have a prominent expression profile in the primary stage of cancer, but, in the metastatic stage, their expression is downregulated, leading to the failure to prevent metastatic cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI